Context Therapeutics CNTX
NASDAQ CNTX
$0.50 -0.02 (-3.77%)
At close: Aug 21, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Property, Plant & Equipment (Net) (2022 - 2026)

Context Therapeutics (CNTX) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Context Therapeutics 48.18 Mn 48.18 Mn - 74,068.00

Historic Data

Download Data
DateValue
Jun 30, 2026 74,068.00
Jun 30, 2026 74,068.00
Mar 31, 2026 62,227.00
Mar 31, 2026 62,227.00
Dec 31, 2025 29,656.00
Dec 31, 2025 29,656.00
Sep 30, 2025 33,721.00
Sep 30, 2025 33,721.00
Jun 30, 2025 37,787.00
Jun 30, 2025 37,787.00
Mar 31, 2025 41,852.00
Mar 31, 2025 41,852.00
Dec 31, 2024 11,959.00
Dec 31, 2024 11,959.00
Sep 30, 2024 14,893.00
Sep 30, 2024 14,893.00
Jun 30, 2024 10,388.00
Jun 30, 2024 10,388.00
Mar 31, 2024 12,956.00
Mar 31, 2024 12,956.00